Jane L. Delgado serves as Executive at Adams Respiratory Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jane L. Delgado has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 29, 2008 involved selling 1,072 shares valued at $64.3K.
Jane L. Delgado currently holds 1,072 shares of Adams Respiratory Therapeutics, Inc. (ARXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane L. Delgado has been a net neutral trader of ARXT stock. They have purchased $0 and sold $0 worth of shares.
Jane L. Delgado's most recent insider trade was on Jan 29, 2008, when they sold 1,072 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 1, 2007 | ARXT | $0 | Award | 323 | $N/A | Discretionary |
| Jul 2, 2007 | ARXT | $0 | Award | 316 | $N/A | Discretionary |
| Apr 19, 2007 | ARXT | $0 | Award | 223 | $N/A | Discretionary |